 for NCI sponsorship, CTEP attempts to fill critical gaps in the national cancer research effort and to avoid duplication of ongoing private sector efforts. In further efforts to control cancer, active new anticancer agents are made available as rapidly and widely as possible for patients. Neurological syndromes have frequently been described in patients with acquired immunodeficiency
for NCI sponsorship, CTEP attempts to fill critical gaps in the national cancer inquiry campaign and to avoid duplication of ongoing individual sector effort. In further efforts to control cancer, active modern anticancer agent are made available as quickly and wide as possible for patients. Neurological syndrome have frequently been described in patients with acquired immunodeficiency
 fog NCI sponsorship, CTEP autempts to fill ctirical japs in the natkonal cancer research effort abd to avoid duplication of ungoing pgivate sextor wfforts. In further efforfd to rontrol cancer, sctive new anticancer agangs are made available as rapidly and ridely ss possible for katiemes. Nslrilogical syndromes have frequsntly bten described in pstients with acquired immujodeviciency
for NCI sponsorship, CTEP attempts to fill in national cancer effort and to sector In further efforts control cancer, active anticancer agents are made available as and widely as possible for patients. Neurological syndromes have frequently been described in with acquired immunodeficiency
 for NCI sponsorship, CTEP atteMpts to fill CritiCal GapS iN the NatiOnal cancer reseARch eFfort and to avoid duplicaTion oF oNGoinG PrIvate Sector eFFoRTS. In FuRtHer EfFOrTs to cOntRol cancEr, active neW anTiCancer agents ARe Made availaBle As rapidly and WidEly as pOsSibLE for pAtiEnts. NEuroloGIcal syNdromes haVe FRequenTLy been dESCrIbed In patients with acqUIrED immunodeficieNcy
 for NCI sponsorship, CTEP  attemptsto fi llcri ti calgaps  in the nation a l ca ncer research effort a nd to  a v oidd up licat ion ofo ng o i ngpr iv ate  s e ct or ef for ts. Infurther ef for ts  to controlc an cer, activ e n ew anticance r a gentsar e m a de av ail ableas rap i dly an d widelyas possib l e for p a t ie nts.  Neurological syn d ro m es have freque ntly b ee n  d e s cri bed  in patien ts  with acquire d  i m m u nod e ficiency
 for_NCI sponsorship,_CTEP attempts to fill_critical gaps_in_the national_cancer_research effort and_to avoid duplication_of ongoing private sector_efforts. In further_efforts_to control cancer, active new anticancer agents are made available as rapidly and widely_as_possible for_patients._Neurological_syndromes have frequently been described_in patients with acquired immunodeficiency